To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
MDBZP (Piperonylpiperazine) or 1-(3,4-methylenedioxybenzyl)piperazine is a piperazine derivative related to the stimulant drug benzylpiperazine. In the book PIHKAL it is speculated that MDBZP might have effects similar to the drug MDMA because of the presence of the 3,4-methylenedioxy group on the benzene ring, however once the compound was tested in humans this theory was shown to be incorrect.
Additional recommended knowledge
MDBZP has been sold as a "Research chemical" with supposed recreational properties, and has even been found as an ingredient in street "ecstasy" pills. However MDBZP is only a very mild stimulant, and does not produce euphoria, empathogenic or psychedelic effects. The prominent effects produced by MDBZP are dizziness, nausea and headaches, but at high doses it has been known to cause convulsions. MDBZP thus has all of the negative side effects of other piperazine derivatives, but without any of the positive effects that might make these drugs desirable to consumers.
|This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Methylenedioxybenzylpiperazine". A list of authors is available in Wikipedia.|